Home » Topics » BioWorld Science

BioWorld Science
RSS

New technique casts light on stem cell differentiation

April 20, 2021

ZX-101A inhibits tumor growth by enhancing antitumor immunity

April 20, 2021

New phase III trial evaluates tafasitamab with lenalidomide and rituximab in FL and MZL

April 20, 2021

TP-5809 shows potent inhibition of tumor growth in a model of Hodgkin's lymphoma

April 20, 2021

Researchers give preclinical details on CARG-2020, an artificial oncolytic virus for ovarian cancer

April 20, 2021

BO-2762: a potential candidate for colorectal cancer

April 20, 2021

Tonix enters into worldwide licensing agreement with OyaGen to develop TNX-3500 for COVID-19

April 20, 2021

Seoul National University discloses vaccine against SFTS virus

April 20, 2021

Suzhou Ark Biopharmaceutical identifies new compounds for HBV infection

April 20, 2021

Betta Pharmaceuticals identifies IDH2 mutant inhibitors

April 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...